Drug intelligence / Profile preview

isoquercetin

Development stage
Phase 3
Lead developer
Quercis Pharma
Modality
Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
Administration
Oral
01

Overview

Isoquercetin is a naturally occurring flavonoid glycoside (specifically, quercetin-3-O-glucoside) found in many medicinal herbs, fruits, and vegetables[8]. It is more bioavailable than its aglycone form (quercetin), due to its glucose moiety which facilitates rapid absorption via sodium-dependent glucose transporter 1 (SGLT-1) in the small intestine[5][3]. Isoquercetin exhibits potent antioxidant activity by scavenging free radicals and inhibiting oxidative damage to cells[4][5]. It also demonstrates anti-inflammatory effects and has been studied for potential benefits in cardiovascular disease, diabetes (as an α-glucosidase inhibitor improving glucose tolerance), allergies, neurological conditions, and cancer[5][8]. Mechanistically, it inhibits protein disulfide isomerase (PDI), contributing to anticoagulant effects relevant for thromboembolism prevention in cancer patients[3]. In preclinical studies on pancreatic cancer cells, isoquercetin induces apoptosis through activation of caspases and cell cycle arrest at the G1 phase[6].

Brand names
Kinisoquin
Other names
quercetin-3-O-glucosidequercetin3-O-glucosidequercetin 3-O-glucosideisoquercitrinquercetin 3-glucosidequercetin3-glucosidequercetin-3-glucosidequercetin-3-beta-D-glucopyranosidequercetin3-beta-D-glucopyranosidequercetin 3-beta-D-glucopyranoside
02

Targets

P4HB (Protein disulfide-isomerase)SIRT6 (Sirtuin 6)Sucrase-IsomaltaseCASP (Caspase family)

Beyond the preview

Go deeper on isoquercetin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on isoquercetin.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call